Marksans Pharma Ltd (BOM:524404)
₹ 298.6 -2.75 (-0.91%) Market Cap: 135.68 Bil Enterprise Value: 131.12 Bil PE Ratio: 40.62 PB Ratio: 6.57 GF Score: 85/100

Q1 2024 Marksans Pharma Ltd Earnings Call Transcript

Aug 16, 2023 / 11:30AM GMT
Release Date Price: ₹114.25 (+0.31%)
Operator

Ladies and gentlemen, good day, and welcome to the Marksans Pharma Q1 FY24 earnings conference call hosted by DAM Capital Advisors Limited. (Operator Instructions) Please note that this conference is being recorded.

I would now like to hand the conference over to Mr. Nitin Agarwal from DAM Capital. Thank you and over to you, sir.

Nitin Agarwal
DAM Capital Advisors Limited - Analyst

Thank you, Carol. Hi, good evening, everyone, and a very warm welcome to Marksans Pharma's Q1 FY24 post-earnings call hosted by DAM Capital Advisors Limited.

On the call today, representing Marksans Pharma, we have Mr. Mark Saldanha, Founder, Chairman and Managing Director; and Mr. Jitendra Sharma, Chief Financial Officer. I'll hand over the call to the Marksans team to make some opening comments, and then we'll open the floor for questions. Please go ahead, sir.

Mark Saldanha
Marksans Pharma Ltd. - MD & CEO

Thank you, Nitin. Welcome, everyone, and thank you for joining us in our Q1 FY24 earnings conference call.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot